Treatment with hyperbaric oxygen in a Crohn's disease patient

dc.coverageDOI: 10.17235/reed.2024.10166/2023
dc.creatorCalderón, Paula
dc.creatorQuera, Rodrigo
dc.creatorNúñez, Paulina
dc.creatorFlores, Lilian
dc.date2024
dc.date.accessioned05-01-2026 18:06
dc.date.available05-01-2026 18:06
dc.description<p>Despite advances in the treatment of inflammatory bowel disease, particularly with biological therapies and new small molecules, a significant gap still exists in achieving persistent remission from a symptomatic, biomarker, and endoscopic perspective. In this context, hyperbaric oxygen therapy (HBOT) is considered as a therapeutic strategy. This approach has also been suggested for managing ischemic ulcers located at anastomotic sites. In this clinical case, we describe the clinical and endoscopic evolution of a challenging-to-manage Crohn's disease (CD) patient with an ischemic ulcer at the ileo-rectal anastomosis who underwent HBOT.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/17e5352a-63c2-428f-977b-c091751cabbd
dc.languageeng
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.116 (2024) nr.11 p.640-641
dc.subjectAnastomosis
dc.subjectCrohn's disease
dc.subjectHyperbaric oxygen
dc.subjectUlcer
dc.titleTreatment with hyperbaric oxygen in a Crohn's disease patienteng
dc.typeLettereng
dc.typeCartaspa
Files
Collections